Donanemab Infusion Triggers Severe Amyloid-Related Imaging Abnormalities (ARIA): Case Study
A 72-year-old patient with early Alzheimer’s disease experienced severe, temporary brain swelling (amyloid-related imaging abnormalities, or ARIA) after receiving donanemab, an experimental antibody therapy. Published this week in Cureus, the ... Read More